Healthcare -
Biotechnology - NASDAQ - US
$ 13.55
0 %
$ 196 M
Market Cap
0.11
P/E
INBX - TOTAL CURRENT LIABILITIES
Total Current Liabilities INBX - Inhibrx Biosciences, Inc.
56.3 M
LAST VALUE
58.36%
2 YEAR CAGR
28.33%
5 YEAR CAGR
0.00%
10 YEAR CAGR